Characterization of the organ donor with bacteremia

D Paredes1, M P Gambra, C Cervera

  • 1Transplant Coordination Service, Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain. dparedes@clinic.ub.es

Transplantation Proceedings
|September 25, 2007
PubMed
Abstract

Insights

Organ donor bacteremia occurs in 14% of cases, often originating from the respiratory tract. Prompt antibiotic treatment for Pseudomonas or S aureus in donors and recipients is recommended to prevent transmission.

Area of Science:

  • Transplantation immunology
  • Infectious disease epidemiology
  • Critical care medicine

Background:

  • Bloodstream infections in organ donors can transmit to recipients.
  • Understanding donor bacteremia is crucial for expanding the organ donor pool.
  • Previous infectious complications, primarily respiratory, were noted in 29% of donors.

Purpose of the Study:

  • To determine the incidence and characteristics of bacteremia in organ donors.
  • To identify pathogens associated with donor bacteremia.
  • To assess the relevance of donor bacteremia for recipient safety.

Main Methods:

  • Retrospective analysis of clinical data from organ donors between 1997 and 2006.
  • Blood cultures were obtained during organ procurement to detect bacteremia.
  • Clinical characteristics, causes of death, and microbiology of donors were described.

Main Results:

  • 14% of 1353 organ donors exhibited bacteremia during procurement.
  • Coagulase-negative Staphylococci (46.2%) were the most common pathogens, followed by S. aureus (15%).
  • Respiratory tract infections were the most frequent source, with Pseudomonas spp. and S. aureus in bronchial cultures indicating higher risk.

Conclusions:

  • Donor bacteremia incidence was 14%, with the respiratory tract as the primary source.
  • The presence of Pseudomonas spp. or S. aureus in bronchial cultures is a risk factor for donor bacteremia.
  • Prophylactic antibiotics targeting these specific microorganisms in both donors and recipients are advised.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...